Get the Stockscreener App
1.92
28.00%
0.42
Ironwood Pharmaceuticals Inc stock is traded at $1.92, with a volume of 4.34M.
It is up +28.00% in the last 24 hours and up +46.56% over the past month.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
See More
Previous Close:
$1.50
Open:
$1.65
24h Volume:
4.34M
Relative Volume:
3.33
Market Cap:
$311.87M
Revenue:
$400.57M
Net Income/Loss:
$9.21M
P/E Ratio:
48.00
EPS:
0.04
Net Cash Flow:
$146.36M
1W Performance:
+15.66%
1M Performance:
+46.56%
6M Performance:
+105.94%
1Y Performance:
-51.39%
1-Day Range:
$1.61
$1.94
1-Week Range:
$1.4705
$1.94
52-Week Range:
$0.5271
$5.1288
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Name
Ironwood Pharmaceuticals Inc
Sector
Phone
617-621-7722
Address
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Compare IRWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.92 | 243.65M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-15-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Sep-09-24 | Initiated | Leerink Partners | Market Perform |
| Aug-08-24 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Jan-17-24 | Initiated | Craig Hallum | Buy |
| Dec-14-23 | Initiated | Wells Fargo | Overweight |
| Nov-09-23 | Initiated | Jefferies | Buy |
| Sep-28-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-02-22 | Initiated | CapitalOne | Overweight |
| Apr-22-22 | Initiated | Piper Sandler | Overweight |
| Sep-30-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-17-20 | Initiated | Northland Capital | Outperform |
| Jul-10-19 | Resumed | Credit Suisse | Neutral |
| Mar-27-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-25-19 | Upgrade | H.C. Wainwright | Sell → Neutral |
| Jan-24-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Nov-07-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Nov-07-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Jul-23-18 | Initiated | H.C. Wainwright | Sell |
| May-09-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-05-18 | Downgrade | BofA/Merrill | Buy → Underperform |
| Dec-06-17 | Downgrade | Mizuho | Buy → Neutral |
| Jul-21-17 | Downgrade | JP Morgan | Overweight → Neutral |
| May-03-17 | Initiated | Wells Fargo | Outperform |
| Apr-07-17 | Reiterated | Mizuho | Buy |
| Feb-22-17 | Reiterated | Barclays | Equal Weight |
| Nov-04-16 | Reiterated | Mizuho | Buy |
| Oct-24-16 | Reiterated | Wedbush | Neutral |
| Oct-10-16 | Reiterated | Mizuho | Buy |
| Sep-27-16 | Reiterated | WallachBeth | Hold |
View All
Ironwood Pharmaceuticals Inc Stock (IRWD) Latest News
Will breakout in Ironwood Pharmaceuticals Inc. lead to full recoveryEarnings Summary Report & Community Driven Trade Alerts - newser.com
Live market analysis of Ironwood Pharmaceuticals Inc.2025 Big Picture & High Win Rate Trade Alerts - newser.com
Ironwood Pharmaceuticals (IRWD) Surges 28% on Strong Linzess Sal - GuruFocus
Ironwood surges 28% as beneficiary of partner AbbVie's Linzess Q3 sales (IRWD:NASDAQ) - Seeking Alpha
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominance2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
Ironwood Pharmaceuticals (IRWD) Expected to Announce Earnings on Thursday - MarketBeat
Will Ironwood Pharmaceuticals Inc. bounce back from current supportJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Is it time to cut losses on Ironwood Pharmaceuticals Inc.July 2025 Action & Weekly Top Stock Performers List - newser.com
Will Ironwood Pharmaceuticals Inc. (I76) stock split increase liquidityWeekly Risk Report & Stock Market Timing Techniques - newser.com
Pattern recognition hints at Ironwood Pharmaceuticals Inc. upsideMarket Weekly Review & Weekly High Return Forecasts - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explained2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
Quantitative breakdown of Ironwood Pharmaceuticals Inc. recent moveMarket Growth Report & Pattern Based Trade Signal System - newser.com
Will Ironwood Pharmaceuticals Inc. stock outperform tech sector in 2025Weekly Trend Report & AI Based Trade Execution Alerts - newser.com
Why Ironwood Pharmaceuticals Inc. stock is a must watch in 2025July 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
What is the fair value of Ironwood Pharmaceuticals Inc. stock now2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
Ironwood Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Will Ironwood Pharmaceuticals Inc. outperform the market2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Published on: 2025-10-28 05:42:32 - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Hold" by Analysts - MarketBeat
How to use a screener to detect Ironwood Pharmaceuticals Inc. breakoutsGap Down & Free Long-Term Investment Growth Plans - newser.com
Will Ironwood Pharmaceuticals Inc. stock reach all time highs in 2025Earnings Trend Report & Safe Entry Trade Signal Reports - Fundação Cultural do Pará
Real time breakdown of Ironwood Pharmaceuticals Inc. stock performance2025 Sector Review & Proven Capital Preservation Methods - newser.com
Aug Macro: Will Ironwood Pharmaceuticals Inc. stock recover faster than market2025 Bull vs Bear & Low Risk High Reward Trade Ideas - Fundação Cultural do Pará
Ironwood Pharmaceuticals Inc Stock (IRWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):